Legal & General Group PLC Pacira Bio Sciences, Inc. Transaction History
Legal & General Group PLC
- $423 Billion
- Q1 2024
A detailed history of Legal & General Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 128,440 shares of PCRX stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,440
Previous 126,353
1.65%
Holding current value
$2.92 Million
Previous $3.69 Million
1.65%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding PCRX
# of Institutions
287Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$116 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$43.5 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$43.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$42.8 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.04B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...